MEMORY FOR DISCRIMINATED ESCAPE LEARNING - PHARMACOLOGICAL ENHANCEMENT AND DISRUPTION

被引:9
|
作者
FORSTER, MJ
POPPER, MD
PAUL, SK
LAL, H
RETZ, KC
机构
关键词
D O I
10.1002/ddr.430110204
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
引用
收藏
页码:97 / 106
页数:10
相关论文
共 50 条
  • [1] LEARNING AND RETENTION OF A DISCRIMINATED ESCAPE RESPONSE IN INFANT MICE
    NAGY, ZM
    MURPHY, JM
    DEVELOPMENTAL PSYCHOBIOLOGY, 1974, 7 (02) : 185 - 192
  • [2] Pharmacological enhancement of dentate gyrus neurogenesis and learning and memory
    Grundke-Iqbal, I.
    Tatebayashi, Y.
    Lee, M. H.
    Iqbal, K.
    JOURNAL OF ALZHEIMERS DISEASE, 2002, 4 (01) : 57 - 57
  • [3] Hemispheric lateralization of memory stages for discriminated avoidance learning in the chick
    Gibbs, ME
    Andrew, RJ
    Ng, KT
    BEHAVIOURAL BRAIN RESEARCH, 2003, 139 (1-2) : 157 - 165
  • [4] SOCIAL DISRUPTION OF DISCRIMINATED AVOIDANCE BEHAVIOR
    FLORY, RK
    FRENCH, K
    PSYCHONOMIC SCIENCE, 1971, 24 (01): : 39 - 40
  • [5] PHARMACOLOGICAL APPROACHES TO LEARNING AND MEMORY
    SANGER, D
    EMMETTOGLESBY, M
    WILLNER, P
    BEHAVIOURAL PHARMACOLOGY, 1992, 3 (04): : 283 - 284
  • [6] Avicenna's pharmacological approach to memory enhancement
    Rahimi, Roja
    Irannejad, Shahrzad
    Noroozian, Maryam
    NEUROLOGICAL SCIENCES, 2017, 38 (07) : 1147 - 1157
  • [7] Pharmacological enhancement of memory or cognition in normal subjects
    Lynch, Gary
    Cox, Conor D.
    Gall, Christine M.
    FRONTIERS IN SYSTEMS NEUROSCIENCE, 2014, 8
  • [8] Avicenna’s pharmacological approach to memory enhancement
    Roja Rahimi
    Shahrzad Irannejad
    Maryam Noroozian
    Neurological Sciences, 2017, 38 : 1147 - 1157
  • [9] EFFECTS OF PYRITINOL ON MAZE ESCAPE LEARNING AND MEMORY
    HASSMANNOVA, J
    MYSLIVECEK, J
    STASTNA, D
    STOILOV, S
    ACTIVITAS NERVOSA SUPERIOR, 1978, 20 (04): : 262 - 264
  • [10] Pharmacological enhancement of synaptic efficacy, spatial learning, and memory through carbonic anhydrase activation in rats
    Sun, MK
    Alkon, DL
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2001, 297 (03): : 961 - 967